Laura Zorzino

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

François‐Clément Bidard, Dieter Peeters, Tanja Fehm et al. · The Lancet Oncology · 2014 · 815 citations

Metastatic Breast Cancer, Breast Oncology, Clinical Validity +8

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

Marco Colleoni, Andrea Rocca, Maria Teresa Sandri et al. · Annals of Oncology · 2002 · 500 citations · Full text

Metastatic Breast Cancer, Oncology, Antitumor Activity +9

Molecular profiling of single circulating tumor cells with diagnostic intention

Bernhard Polzer, Gianni Medoro, Sophie Pasch et al. · EMBO Molecular Medicine · 2014 · 250 citations · Full text

N-Terminal Pro-B-Type Natriuretic Peptide after High-Dose Chemotherapy: A Marker Predictive of Cardiac Dysfunction?

Maria Teresa Sandri, Michela Salvatici, Daniela Cardinale et al. · Clinical Chemistry · 2005 · 242 citations · Full text

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects

Marco Colleoni, Laura Orlando, Giuseppina Sanna et al. · Annals of Oncology · 2005 · 187 citations · Full text

Metastatic Breast Cancer, Antitumor Activity, Biological Effects +12